Obsessive-compulsive symptoms in substance use disorder
Part of Mental health clinical trials.
This study looks at whether people with substance use disorder have more obsessive-compulsive symptoms (repetitive thoughts and behaviors) compared with people who do not use substances. If you have a substance use problem, participating helps researchers understand these symptoms better, which may lead to improved treatment and support.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 50 years old.
- You must be willing to sign a consent form and complete the study assessments.
- For the main group: you need a diagnosis of substance use disorder (single or multiple substances). For the control group: you must be a relative, friend, or hospital worker without substance use disorder.
- You cannot have severe psychiatric conditions like schizophrenia, major depressive disorder, bipolar disorder, or anorexia nervosa.
- You cannot be currently intoxicated or in acute withdrawal from substances.
- You cannot have severe medical conditions like end-stage kidney disease, metastatic cancer, severe heart failure, or severe COPD, and you must not have severe cognitive impairment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people with obsessive-compulsive disorder (OCD) over time to better understand how the condition progresses and how people respond to different treatments. By joining, you help researchers learn more about OCD, which could improve future care for others.
This study looks at obsessive-compulsive disorder (OCD) in children and young adults to better understand and document treatment and experiences. It may help researchers learn what supports work best for young people with OCD.
This study looks at genes, blood/brain proteins, and gut microbes in people with obsessive-compulsive disorder (OCD). It may help researchers understand what drives OCD and how treatments could be better tailored in the future.
This trial tests whether MDMA plus cognitive behavioral therapy (CBT) can reduce OCD symptoms in adults who have tried standard OCD treatments before. You may be asked to pause certain medicines and follow specific diet/medication rules around the study session.
This study uses brain imaging and thinking tasks to learn more about how the brain works in people with OCD compared to healthy volunteers. It aims to understand the differences to improve future treatments.
This study looks at how alcohol and substance use affects people with schizophrenia or bipolar disorder. It aims to understand if having these conditions together changes treatment or outcomes.
Hear when a new Obsessive-Compulsive Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.